Ixekizumab Results in Persistent Clinical Improvement in Moderateto-Severe Genital Psoriasis During a 52 Week, Randomized, Placebo-Controlled, Phase 3 Clinical Trial

por GUENTHER, Lyn, BLEAKMAN, Alison POTTS, WEISMAN, Jamie, POULIN, Yves, SPELMAN, Lynda, BURGE, Russel, ERICKSON, Janelle, TODD, Kristin, BERTRAM, Clinton C., RYAN, Caitriona
Publicado 2020